Biosynthesis of 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), a possible antiparkinsonism agent.
Tasaki
Y
Y
Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.
Makino
Y
Y
Ohta
S
S
Hirobe
M
M
D000818:Animals; D000978:Antiparkinson Agents / Q000378:metabolism*; D001921:Brain / Q000378:metabolism*; D046508:Culture Techniques; D008401:Gas Chromatography-Mass Spectrometry; D007546:Isoquinolines / Q000378:metabolism*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010627:Phenethylamines / Q000378:metabolism; D044005:Tetrahydroisoquinolines
D000978:Antiparkinson Agents; D007546:Isoquinolines; D010627:Phenethylamines; D044005:Tetrahydroisoquinolines; C029261:phenethylamine; C050386:1-methyl-1,2,3,4-tetrahydroisoquinoline